The Department said the Office for Investment was set up to improve cross-government coordination on high-value strategically important investments, as the government recognised this was an area for improvement. It said that the Office for Investment was able to leverage the brand and authority of Downing Street through its links with the Number 10 Business Unit, both for bringing together other departments to support investment projects, and to demonstrate to investors that the government values them.57 It gave the example of BioNTech, which had recently signed an agreement with the government to do clinical trials in the UK over the next ten years, and is expected to invest several hundreds of millions. The Department explained that the Office for Investment had helped support the investment by arranging a meeting between the BioNTech founders and relevant senior stakeholders from across the health service, relevant government departments and regulators. The Department told us that it had received very positive feedback from BioNTech though it recognised the meeting likely had a marginal impact in terms of influencing BioNTech to choose the UK for its investment.58